Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pathogenesis of atherosclerosis

J P Segrest¹, G M Anantharamaiah

¹Department of Medicine, University of Alabama Medical Center, Birmingham.

Current Opinion in Cardiology

|July 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular Mechanisms Governing Peptide Nanodisc Assembly and Stability.

bioRxiv : the preprint server for biology·2026

Same author

Peptide nanodiscs: Versatile platforms for membrane protein functional reconstitution and structural studies: A review.

International journal of biological macromolecules·2025

Same author

Bifunctional nanodisc platforms for studies on self-assembly and amyloid fibrillation.

Chemical communications (Cambridge, England)·2025

Same author

Characterization of nanodisc-forming peptides for membrane protein studies.

Journal of colloid and interface science·2023

Same author

Peptides as Therapeutic Agents for Atherosclerosis.

Methods in molecular biology (Clifton, N.J.)·2022

Same author

Nanodisc reconstitution of flavin mononucleotide binding domain of cytochrome-P450-reductase enables high-resolution NMR probing.

Chemical communications (Cambridge, England)·2021

Same journal

Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.

Current opinion in cardiology·2026

Same journal

Viability testing for guiding revascularization in ischemic cardiomyopathy.

Current opinion in cardiology·2026

Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026

Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026

Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026

Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026

See all related articles

Aggressive lipid-lowering therapy rapidly halts coronary artery disease events by removing cholesterol from cells. Studies show apolipoprotein A-I inhibits atherosclerosis, while remnant particles promote it.

Area of Science:

Cardiovascular Biology
Atherosclerosis Research
Lipoprotein Metabolism

Background:

Plasma lipoproteins play a key role in atherosclerotic plaque formation.
Recent studies highlight the impact of lipid modification therapies and specific apolipoproteins on cardiovascular health.

Purpose of the Study:

To review recent developments supporting the role of plasma lipoproteins in plaque formation.
To discuss the potential of circulating factors in assessing endothelial dysfunction.
To explore the role of fibrin-like peptides in atherogenesis and coronary artery disease risk.

Main Methods:

Review of recent clinical findings on lipoprotein-modifying therapy.
Analysis of transgenic mouse studies involving apolipoproteins A-I and E.

Related Experiment Videos

Discussion of emerging research on endothelial dysfunction markers and fibrin-like peptides.

Main Results:

Aggressive lipoprotein-modifying therapy leads to plaque stabilization and rapid cessation of coronary artery disease events.
Apolipoprotein A-I (high-density lipoprotein) demonstrates significant inhibition of atherosclerosis development.
Remnant lipoprotein particles are identified as atherogenic.

Conclusions:

Plasma lipoproteins are critical in the pathogenesis of atherosclerosis.
Apolipoprotein A-I and high-density lipoprotein are protective against atherosclerosis.
Further research into circulating factors and fibrin-like peptides may offer new avenues for assessing endothelial dysfunction and coronary artery disease risk.